FUJIFILM Biotechnologies’ Lars Petersen Named “CEO of the Year” at CPHI Pharma Awards 2025

FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organization for biologics, vaccines, and advanced therapies, is proud to celebrate that its president and CEO Lars Petersen has been named “CEO of the Year” at the CPHI Pharma Awards 2025 in Frankfurt, Germany. The annual global CPHI event brings together 62,000 professionals from the entire pharmaceutical supply chain.

CPHI’s “CEO of the Year” award recognizes outstanding leadership within the pharma industry. The jury is comprised of independent, senior industry experts from around the world, and evaluation criteria is based on examples of exceptional leadership.

Petersen was awarded “CEO of the Year” for his transformational leadership within the CDMO industry. Since taking the helm as CEO of FUJIFILM Biotechnologies two years ago, Petersen has advocated for trust-based partnerships with employees, customers and industry, and pioneered a “people first” culture within the organization. Additionally, under Petersen’s leadership, FUJIFILM Biotechnologies is rapidly scaling with the recent opening of its US commercial-scale manufacturing hub, and additional expansions coming online across its global network in 2026 – which will fulfill Petersen’s vision of creating the industry’s largest interconnected modular network of biomanufacturing facilities.

“I am truly honored for this recognition and want to thank the CPHI and Informa Markets teams, as well as the panel of judges. This recognition belongs to FUJIFILM Biotechnologies’ incredible team of 5,000 professionals across the globe. Each of you embodies Fujifilm’s purpose of ‘Giving our world more smiles’ by making medicines possible,” said Petersen. “Together we are evolving the CDMO industry to help our partners to create a healthier world.”